working
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Trades 702 and 1053?
Accepting that you are not lying to us, your position is very easy, if you are right about Leo ... you win and if Brilacidin succeeds ... you win
I agree, it is also very unusual in these cases not to experience a price increase in anticipation of the results, regardless of how they are the same.
That is the most logical and usual and here it is not happening
The "detractors", "shorts" etc is not the excuse, it exists on all OTC boards
If investors today rush to buy the PPS goes up, it's that simple,
Why do not they do it? because they don't know Brilacidin, they don't trust the CEO, it's an OTC company ... namely
The opinions of the detractors of this message board are nothing, insignificant in the market, sometimes it seems that only we exist
without volume it is difficult
Exactly, this woman's husband is raising money for hospital treatment, and the last contribution was a few hours ago
Anyone can make a donation for this family that is having a hard time
Simply proof that he has not passed away, but the human part is the important thing
Nothing new, information about places, medical specialists, etc.
It seems more revealing to me the information that the person who was administered Brilacidin (the one we know her name) has not died, contrary to what has been published here
a joy for the family,
A little information about Russia, with chrome translator all ready
"...and we already know that at least one CU patient receiving brilacidin has died."
the only patient we know of is the one in the Palmbeachpost article, and that patient has not died
You only have to do DD on social networks, but out of respect for this lady I will not put the link
I Agree, incredible but that's the way it is, nobody is aware of IPIX right now, except us and "four more"
I agree, nobody knows anything, otherwise the volume would be completely different, both for good and for bad,
only nobody buys, but it is a dangerous game ...
I don't think we have many eyes on us, but that will change, good or bad
the manipulators, shorts etc, are playing with fire
if we are right of course ...
I think the PR with the PII data will be with the open market
AVIR -73% It is also true that I go from 1$ to 80$ (before results)
Dangerous game, let's imagine we have the data tomorrow or tonight
I have been here for years, I will wait quietly, we are in a better position than we have ever been
..."Based on information received from the data management and biostatistics vendors, study unblinding, analysis of the unblinded data and release of topline study results for the Brilacidin COVID-19 trial is anticipated to occur in mid-to-late October"
Better not to create false expectations, it can be today or in the next fifteen days,
So much expectation of PR today feeds the detractors in case of not taking place
The PR says it clear, "mid-to-late October"
IPIX run
wall in 0.23$ LOL
hitting the ASK. IPIX
when we are given a clue about something, it is because it will already be done,
I am amazed, how good you are at trading!
The circle is increasingly closed, classic compensation, the CEO positions himself for the Boooommm
As a 47-year-old Loxahatchee woman clung to life in an intensive care unit on Wednesday, attorneys faced off in court over whether Palm Beach Gardens Medical Center could be forced to give her the experimental drug Ivermectin to help her battle COVID-19.
Attorney Jake Huxtable, who represents Tamara Drock’s husband, said hospital officials had agreed to give the Egret Lake Elementary School teacher the anti-parasitic drug, which hasn’t been approved for use to treat the highly infectious respiratory disease.
Negotiations broke down over the dosage of Ivermectin she should receive, he told Palm Beach County Circuit Judge James Nutt during a 20-minute hearing.
More: Kravis, Norton, Armory Arts Center, iTHINK amphitheatre probed by state over vaccine passports
More: Lawsuits demand Palm Beach County hospitals give Ivermectin to struggling COVID patients
More: A rare breakthrough case: COVID-19 kills ex-Post employee, a fully vaxxed 58-year-old man
More: How often do fully vaccinated people die from rare breakthrough infections of COVID?
“We were under the impression she was going to get her first dose yesterday,” Huxtable said. Then the unexpected roadblock developed.
Huxtable said time is running out. Since he filed the emergency petition on Oct. 1, both of Drock’s lungs have collapsed, so she can no longer use a ventilator. Drock, who isn’t vaccinated, is receiving oxygen through tubes.
“My client has the freedom of choice,” he said of Drock’s husband, Ryan. “He has the right to give his wife any last chance to live, including this drug, Ivermectin.”
Ryan and Tamara Drock both have contracted the coronavirus and COVID-19, the respiratory ailment it causes. Ryan recovered but Tamara is at Palm Beach Gardens Medical Center, where Ryan wants a judge to order the hospital to give her the drug Ivermectin, which he says helped him recover. Doctors note it hasn't been found effective against COVID-19.
Ryan and Tamara Drock both have contracted the coronavirus and COVID-19, the respiratory ailment it causes. Ryan recovered but Tamara is at Palm Beach Gardens … Mostrar más
HANDOUT PHOTO
Nutt, who was on a break from a jury trial, said he didn’t want to hear the details of the case.
Instead, he said, he wanted to make sure the correct procedures are being followed. He asked Huxtable and hospital attorney Isaac Ruiz-Carus to send him an email, outlining their positions.
Ruiz-Carus, who claimed that the lawsuit wasn’t filed properly, bristled at Huxtable’s claims that the hospital agreed to give Drock the experimental drug.
“We don’t have a settlement, so getting into the details of that would be inappropriate,” he said.
Further, the Tampa attorney said, the hospital hasn’t received a copy of the lawsuit, a key requirement for it to move forward. Huxtable countered that officials at the hospital, owned by Tenet Healthcare, are well aware of the suit but have thwarted efforts to be served formally.
Tamara Drock is a COVID-19 patient at Palm Beach Gardens Medical Center, seen here on a ventilator. Her husband, Ryan, says Ivermectin cured his bout of COVID and wants a judge to order the hospital to provide it to his wife, over the objections of doctors.
Tamara Drock is a COVID-19 patient at Palm Beach Gardens Medical Center, seen here on a ventilator. Her husband, Ryan, says Ivermectin cured his bout … Mostrar más
HANDOUT PHOTO
Husband: 'This hospital should be ashamed of itself'
In a statement, Ryan Drock said he was “appalled and disgusted” by the hospital’s actions.
After signing a confidentiality agreement, promising to not tell anyone that the hospital would give his wife Ivermectin, he said hospital officials refused to give her a meaningful dose of the medication.
“So now, unfortunately, I am left with no choice but to go through the court system in hopes of being able to get this medicine to my wife in time before she dies to try and save her life,” he said. "This hospital should be ashamed of itself.”
The hearing marked the second time in less than two weeks that a county judge has been asked to decide whether an area hospital should be ordered to give a gravely ill COVID-19 patient the drug that is widely used to treat people for worms.
More: Six Palm Beach County hospitals loosen visitor restrictions as COVID-19 infections decline
More: For first time in months, less than 5% of Florida COVID-19 test results are positive
Similar cases have been filed across the country with the help of a Buffalo, New York, law firm.
In the other Palm Beach County case, Bethesda Hospital East in Boynton Beach agreed to give Ivermectin to 65-year-old Glenn Stephanos. The accord was reached after Circuit Judge John Kastrenakes asked hospital officials and the Jupiter man’s wife to try to settle the case.
Huxtable argued that other hospitals in South Florida, including those run by Broward Health, are using Ivermectin to help patients battle COVID-19. Officials at the Fort Lauderdale-based health system didn’t return an email asking for comment.
He cited a 2020 study of 280 patients at Broward Health’s four hospitals. It found fewer COVID-19 patients died after being treated with Ivermectin. It was particularly potent in patients with “severe pulmonary involvement,” researchers said.
“That is precisely what Mrs. Drock has,” Huxtable told Nutt.
But those who conducted the study, which is posted on the website of the National Library of Medicine, also said the results were preliminary.
“Randomized controlled trials are needed to confirm these findings,” they wrote.
The National Institutes of Health, which houses the library on its campus, said no studies have shown that Ivermectin is effective in treating COVID-19.
An Egyptian study, which was widely hailed after it showed Ivermectin reduced COVID-19 deaths by 90%, was retracted in July after questions were raised about possible plagiarism and concerns about the interpretation of the data.
Doctor: Bowing to 'family pressures is a dangerous precedent'
Both the NIH and the Food and Drug Administration have refused to bless the use of Ivermectin, saying more study is needed.
Further, they say, the buzz around Ivermectin has caused some people to use an injectable form that is only approved for use in horses, cattle and other livestock. That, they said, can be deadly.
But, Huxtable said, another medication that hasn’t gotten FDA approval is being used to treat COVID-19 patients. Drock signed a special release so his wife could receive the drug Brilacidin, he told Nutt.
But, unlike Ivermectin, the FDA has allowed the drug to be used in clinical trials with hospitalized COVID-19 patients.
Doctors say the legal battles are worrisome.
Dr. Kitonga Kiminyo, a Boynton Beach infectious disease specialist, compared the misplaced hope in Ivermectin to the furor created early in the pandemic when former President Donald Trump falsely claimed hydroxychloroquine could cure COVID-19.
“We found it had absolutely no effect on reducing hospitalizations, reducing complications or reducing death,” Kiminyo said. “We stopped using hydroxychloroquine. We started and stopped.”
Not only was the antimalarial drug ineffective, but it also had the potential to cause heart problems.
“We don’t want to cause harm,” Kiminyo said, referring to the Hippocratic Oath.
More: Publix, Winn-Dixie, CVS, and more: How and where to get a COVID-19 booster shot in Florida
More: Why recent COVID levels in Jupiter-area sewage are giving officials cause for optimism
Not enough study has been done to know the effects of Ivermectin. “We don’t know, so there’s always a potential for harm,” he said.
Kiminyo said he understands that families are desperate. They are grasping at anything to keep their loved ones alive.
“But bowing to family pressures is a dangerous precedent,” he said. “Then we would have family members asking us to give patients all kinds of drugs.”
In the nearly two years since the novel coronavirus first surfaced, doctors have learned how to treat it, he said.
More: The latest news about COVID-19, mask mandates, vaccines and more
But, he said, drugs and treatments, such as remdesivir and monoclonal antibody therapy, have to be administered soon after infection. If people aren’t given the anti-viral remdesivir and other drugs within 10 days of contracting the virus, the prognosis is grim.
“They don't work when someone’s been fighting COVID for weeks and weeks,” he said.
By the time someone is on a ventilator, the virus has already wreaked havoc in the body. Lungs have become grievously scarred and other organs are hopelessly damaged, he said.
“The ramifications are horrible. It’s death,” Kiminyo said.
Unfortunately, he said, Ivermectin and other unproven treatments are being touted by doctors who are willing to disregard science. They are among the same physicians who have urged people not to get vaccinated, which is proven to save lives, he said.
“It’s that mistrust that allows some doctors to give Ivermectin,” he said. “Instead of believing in the science, they are more likely to believe in hoaxes rather than the tried and true.”
Just sit and wait, there's no rush
It is preferable to a veterinary medicine without any benefit
my reading goes further,
Brilacidine is being administered in hospitals, with family consent and "permission" from the FDA without being approved,
Now tell me, what is the result of phase II?
I tell him: FAVORABLE
"...But, Huxtable said, another medication that hasn’t gotten FDA approval is being used to treat COVID-19 patients. Drock signed a special release so his wife could receive the drug Brilacidin, he told Nutt."
https://eu.palmbeachpost.com/story/news/coron...437265002/
We have the answer, it is being used and is being used with permission from the FDA, why? because the results are good
exactly, a pity, like the millions of dead around the world.
But from an investment point of view, brilacidine is being used without approval but with the "permission" of the FDA,
Why does the FDA allow it? Well, in my town they say "WHITE AND IN A BOTTLE"
better do this reading: Brilacidine is being administered without being approved yet by the FDA, but with the "permission" of this
a small company, in OTC, with a CEO according to many of dubious reputation,
Can you imagine why?
I tell you,
because it works !!!
https://eu.palmbeachpost.com/story/news/coronavirus/2021/10/13/covid-patients-request-ivermectin-denied-hospital-lawyer-claims/8437265002/
"...But, Huxtable said, another medication that hasn’t gotten FDA approval is being used to treat COVID-19 patients. Drock signed a special release so his wife could receive the drug Brilacidin, he told Nutt."
it's over MRK is still on your way to 75-76 $
WAKEFIELD, MA / September 23, 2021 / ACCESSWIRE Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, today provided an update on the status of its randomized, double-blind, placebo-controlled Phase 2 clinical trial of Brilacidin for the treatment of moderate-to-severe COVID-19 in hospitalized patients (see NCT04784897), as well as related news.
Based on information received from the data management and biostatistics vendors, study unblinding, analysis of the unblinded data and release of topline study results for the Brilacidin COVID-19 trial is anticipated to occur in mid-to-late October. The Company looks forward to the data to learn if Brilacidin’s multiple properties translate into meaningful clinical results, given the unmet need for COVID-19 therapeutics and ongoing pandemic.
In the last PR it does not say that we will have news of data blocking in advance
PR:...mid-to-late October
LOL 0.23
and while we're at ... 0.22$
Over time we will have several therapies, as has happened with vaccines, new vaccines will even appear, I do not think it is a problem,